.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Citi
Moodys
Argus Health
McKesson
Cerilliant
Harvard Business School
Mallinckrodt
Novartis
Fuji

Generated: December 12, 2017

DrugPatentWatch Database Preview

Kyowa Kirin Company Profile

« Back to Dashboard

What is the competitive landscape for KYOWA KIRIN, and when can generic versions of KYOWA KIRIN drugs launch?

KYOWA KIRIN has two approved drugs.

There is one US patent protecting KYOWA KIRIN drugs on KYOWA KIRIN drugs in the past three years.

There are thirty-seven patent family members on KYOWA KIRIN drugs in thirty-one countries and one supplementary protection certificate in one country.

Summary for Kyowa Kirin

International Patents:37
US Patents:1
Tradenames:2
Ingredients:2
NDAs:2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Kyowa KirinFARESTONtoremifene citrateTABLET;ORAL020497-001May 29, 1997RXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
Kyowa KirinSANCUSOgranisetronFILM, EXTENDED RELEASE;TRANSDERMAL022198-001Sep 12, 2008RXYesYes► Subscribe► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Kyowa Kirin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Kyowa KirinFARESTONtoremifene citrateTABLET;ORAL020497-001May 29, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for KYOWA KIRIN drugs

Drugname Dosage Strength Tradename Submissiondate
granisetron hydrochloride Transdermal System 3.1 mg/24 hrs SANCUSO 10/9/2015

International Patent Family for Kyowa Kirin Drugs

Country Document Number Estimated Expiration
South Africa200506128► Subscribe
Poland379027► Subscribe
Hong Kong1082199► Subscribe
Slovenia1589956► Subscribe
China102526043► Subscribe
Serbia51696► Subscribe
Austria368454► Subscribe
World Intellectual Property Organization (WIPO)2004069141► Subscribe
Norway20053663► Subscribe
European Patent Office1589956► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Kyowa Kirin Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
C0029Belgium► SubscribePRODUCT NAME: TOREMIFENE; REGISTRATION NO/DATE: EU/1/96/004/001 19960215
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
UBS
Harvard Business School
Merck
Colorcon
AstraZeneca
Federal Trade Commission
Argus Health
Deloitte
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot